SI2928881T1 - New pyridine derivatives - Google Patents

New pyridine derivatives Download PDF

Info

Publication number
SI2928881T1
SI2928881T1 SI201331023T SI201331023T SI2928881T1 SI 2928881 T1 SI2928881 T1 SI 2928881T1 SI 201331023 T SI201331023 T SI 201331023T SI 201331023 T SI201331023 T SI 201331023T SI 2928881 T1 SI2928881 T1 SI 2928881T1
Authority
SI
Slovenia
Prior art keywords
pyridine
cyclopropylmethoxy
amide
carboxylic acid
carbamoylmethyl
Prior art date
Application number
SI201331023T
Other languages
English (en)
Slovenian (sl)
Inventor
Beat Frei
Luca Gobbi
Uwe Grether
Atsushi Kimbara
Matthias Nettekoven
Stephan Roever
Mark Rogers-Evans
Tanja Schulz-Gasch
Original Assignee
F.Hoffmann-La RocheAG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La RocheAG filed Critical F.Hoffmann-La RocheAG
Publication of SI2928881T1 publication Critical patent/SI2928881T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SI201331023T 2012-12-07 2013-12-02 New pyridine derivatives SI2928881T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12196022 2012-12-07
PCT/EP2013/075225 WO2014086705A1 (en) 2012-12-07 2013-12-02 Novel pyridine derivatives
EP13799520.5A EP2928881B1 (en) 2012-12-07 2013-12-02 Novel pyridine derivatives

Publications (1)

Publication Number Publication Date
SI2928881T1 true SI2928881T1 (en) 2018-07-31

Family

ID=47290804

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201331023T SI2928881T1 (en) 2012-12-07 2013-12-02 New pyridine derivatives

Country Status (33)

Country Link
US (1) US9522886B2 (cg-RX-API-DMAC7.html)
EP (2) EP3357918A1 (cg-RX-API-DMAC7.html)
JP (1) JP6426618B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150092282A (cg-RX-API-DMAC7.html)
CN (2) CN107674061A (cg-RX-API-DMAC7.html)
AR (1) AR093843A1 (cg-RX-API-DMAC7.html)
AU (2) AU2013354278B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015012919A2 (cg-RX-API-DMAC7.html)
CA (1) CA2890100A1 (cg-RX-API-DMAC7.html)
CL (1) CL2015001536A1 (cg-RX-API-DMAC7.html)
CO (1) CO7350620A2 (cg-RX-API-DMAC7.html)
CR (1) CR20150250A (cg-RX-API-DMAC7.html)
DK (1) DK2928881T3 (cg-RX-API-DMAC7.html)
EA (1) EA026669B1 (cg-RX-API-DMAC7.html)
ES (1) ES2668690T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20180672T1 (cg-RX-API-DMAC7.html)
HU (1) HUE036911T2 (cg-RX-API-DMAC7.html)
IL (1) IL239075B (cg-RX-API-DMAC7.html)
LT (1) LT2928881T (cg-RX-API-DMAC7.html)
MA (1) MA38239A1 (cg-RX-API-DMAC7.html)
MX (1) MX2015007155A (cg-RX-API-DMAC7.html)
NO (1) NO2928881T3 (cg-RX-API-DMAC7.html)
PE (1) PE20151025A1 (cg-RX-API-DMAC7.html)
PH (1) PH12015501083B1 (cg-RX-API-DMAC7.html)
PL (1) PL2928881T3 (cg-RX-API-DMAC7.html)
PT (1) PT2928881T (cg-RX-API-DMAC7.html)
RS (1) RS57143B1 (cg-RX-API-DMAC7.html)
SG (2) SG10201800170YA (cg-RX-API-DMAC7.html)
SI (1) SI2928881T1 (cg-RX-API-DMAC7.html)
TW (1) TWI600645B (cg-RX-API-DMAC7.html)
UA (1) UA114656C2 (cg-RX-API-DMAC7.html)
WO (1) WO2014086705A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201503969B (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2964646B1 (en) 2013-03-07 2017-04-19 F. Hoffmann-La Roche AG Novel pyrazol derivatives
CA2899168A1 (en) 2013-03-26 2014-10-02 F. Hoffmann-La Roche Ag Novel pyridine derivatives
ES2635632T3 (es) 2013-05-02 2017-10-04 F. Hoffmann-La Roche Ag Derivados de pirrolo[2,3-d]pirimidina como agonistas del receptor CB2
PT2991987T (pt) 2013-05-02 2018-07-13 Hoffmann La Roche Derivados de purina como agonistas do recetor cb2
CA2915766C (en) 2013-09-06 2023-09-26 F. Hoffmann-La Roche Ag Triazolo[4,5-d]pyrimidine derivatives and their use as cannabinoid receptor 2 agonists
KR20160132495A (ko) * 2014-04-04 2016-11-18 에프. 호프만-라 로슈 아게 카나비노이드 수용체 작용제로서 5,6-이치환된 피리딘-2-카복스아미드
EP3156397B1 (en) 2014-06-13 2019-08-07 Takeda Pharmaceutical Company Limited Nitrogen-containing heterocyclic compound
DK3386951T3 (en) * 2015-12-09 2020-04-27 Hoffmann La Roche Phenylderivater som cannabinoidreceptor-2-agonister
WO2017107089A1 (en) 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. 3- (1h-pyrazol-4-yl) pyridineallosteric modulators of the m4 muscarinic acetylcholine receptor
EP3642200B1 (en) 2017-06-20 2023-05-03 F. Hoffmann-La Roche AG Pyridine derivatives
CN112041309A (zh) * 2018-04-18 2020-12-04 巴斯夫欧洲公司 D-葡糖二酸-6,3-内酯单酯及其制备方法
CN112074513B (zh) 2018-06-27 2024-06-14 豪夫迈·罗氏有限公司 作为优先大麻素2激动剂的吡啶和吡嗪衍生物
JP7478672B2 (ja) * 2018-06-27 2024-05-07 エフ． ホフマン－ラ ロシュ アーゲー カンナビノイド受容体２の阻害剤としての新規なアゼチジン置換ピリジン及びピラジン化合物
MA53002A (fr) 2018-06-27 2021-05-05 Eth Zuerich Nouveaux composés de pyridine et de pyrazine en tant qu'inhibiteurs du récepteur cannabinoïde 2
EP3813888B1 (en) 2018-06-27 2025-11-26 F. Hoffmann-La Roche AG Radiolabeled cannabinoid receptor 2 ligand
EP4038055A1 (en) * 2019-09-30 2022-08-10 F. Hoffmann-La Roche AG Substituted 3,4-dihydroquinazoline for the treatment and prophylaxis of hepatitis b virus infection
CA3192236A1 (en) 2020-09-10 2022-03-17 Tony Lahoutte Antibody fragment against fap
EP4326257A4 (en) 2021-04-19 2025-03-12 ChemoCentryx, Inc. AZETIDINYLACETAMIDES AS CXCR7 INHIBITORS
WO2023203135A1 (en) 2022-04-22 2023-10-26 Precirix N.V. Improved radiolabelled antibody
JP2025517625A (ja) 2022-05-02 2025-06-10 プレシリックス・ナームローゼ・ベンノートシヤープ プレターゲティング

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009003316A (es) 2006-10-04 2009-04-09 Hoffmann La Roche Derivados de pirazina-2-carboxamida como moduladores receptores de cb2.
WO2012031817A1 (en) * 2010-09-09 2012-03-15 F. Hoffmann-La Roche Ag Determination of abca1 protein levels in cells
AR085013A1 (es) * 2011-01-26 2013-08-07 Sanofi Aventis Derivados de acido 3-heteroaroilamino-propionico sustituidos y su uso como sustancias farmaceuticas
US9321727B2 (en) 2011-06-10 2016-04-26 Hoffmann-La Roche Inc. Pyridine derivatives as agonists of the CB2 receptor

Also Published As

Publication number Publication date
HK1208031A1 (en) 2016-02-19
HUE036911T2 (hu) 2018-08-28
LT2928881T (lt) 2018-06-11
RS57143B1 (sr) 2018-07-31
US20150307452A1 (en) 2015-10-29
MA38239A1 (fr) 2017-03-31
US9522886B2 (en) 2016-12-20
CA2890100A1 (en) 2014-06-12
CN107674061A (zh) 2018-02-09
DK2928881T3 (en) 2018-05-28
EP2928881A1 (en) 2015-10-14
CR20150250A (es) 2015-06-11
MX2015007155A (es) 2015-10-14
TW201427951A (zh) 2014-07-16
ES2668690T3 (es) 2018-05-21
AR093843A1 (es) 2015-06-24
CL2015001536A1 (es) 2015-10-23
CO7350620A2 (es) 2015-08-10
AU2013354278A1 (en) 2015-05-14
EA026669B1 (ru) 2017-05-31
KR20150092282A (ko) 2015-08-12
NO2928881T3 (cg-RX-API-DMAC7.html) 2018-08-11
PL2928881T3 (pl) 2018-07-31
PE20151025A1 (es) 2015-07-15
PT2928881T (pt) 2018-05-07
IL239075A0 (en) 2015-07-30
IL239075B (en) 2018-11-29
CN104837831B (zh) 2017-10-31
ZA201503969B (en) 2016-04-28
SG11201504416XA (en) 2015-07-30
EP3357918A1 (en) 2018-08-08
WO2014086705A1 (en) 2014-06-12
PH12015501083A1 (en) 2015-08-03
BR112015012919A2 (pt) 2017-07-11
JP2016501240A (ja) 2016-01-18
UA114656C2 (uk) 2017-07-10
EP2928881B1 (en) 2018-03-14
JP6426618B2 (ja) 2018-11-21
HRP20180672T1 (hr) 2018-06-01
PH12015501083B1 (en) 2015-08-03
SG10201800170YA (en) 2018-02-27
AU2013354278B2 (en) 2017-10-12
CN104837831A (zh) 2015-08-12
AU2017279648A1 (en) 2018-01-18
EA201591064A1 (ru) 2015-09-30
TWI600645B (zh) 2017-10-01

Similar Documents

Publication Publication Date Title
SI2928881T1 (en) New pyridine derivatives
JP2016501240A5 (cg-RX-API-DMAC7.html)
RU2419624C2 (ru) Сульфонамидные производные как активаторы гликокиназы, применимые для лечения диабета типа 2
CN104837818B (zh) 可用作cb2激动剂的吡啶‑2‑酰胺
US9242977B2 (en) Trk-inhibiting compound
JP5997265B2 (ja) Ｃｂ２アゴニストとして有用なピリジン−２−アミド
JP6397410B2 (ja) 芳香環化合物
JP6500010B2 (ja) 新規ピリジン誘導体
JP3922884B2 (ja) ベンゾフリルピロン誘導体
JP2019069941A (ja) スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用
HRP20170572T1 (hr) Derivati pirazina kao agonisti receptora cb2
RU2015121948A (ru) Агонист рецептора gpr40, способы его получения и фармацевтические композиции, содержащие его в качестве активного ингредиента
KR101615779B1 (ko) 면역조절제로서 피리딘-2-일 유도체
ME02297B (me) Jedinjenja koja imaju aktivnost antagonista muskarinskih receptora i agonist beta2 adrenergičnog receptora
PE20121440A1 (es) Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurologicos
KR20150137095A (ko) 치환된 옥소피리딘 유도체 및 심혈관 장애의 치료에서의 그의 용도
BR112012028527A2 (pt) composto de amida, composição farmacêutica e inibidor de 11â-hsd1 compreendendo o dito composto e usos do dito composto
JP2008513516A5 (cg-RX-API-DMAC7.html)
HRP20100522T1 (hr) Piridin karboksamidi kao inhibitori 11-beta-hsd1
HRP20161702T1 (hr) Novi derivati pirazina
JPWO1999046262A1 (ja) ベンゾフリルピロン誘導体
TW202208359A (zh) 新穎二醯基甘油酯o-醯基轉移酶2抑制劑
CN116507613A (zh) 稳定转甲状腺蛋白四聚体的视黄醇结合蛋白4的双特异性拮抗剂及其制备和在治疗常见年龄相关合并症中的用途
JP7482324B2 (ja) 新規なジアシルグリセリドｏ－アシルトランスフェラーゼ２阻害剤としてのオキシインドール誘導体の製造
CN103842341A (zh) 新型雌激素受体配体